These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11099714)

  • 21. Variable platelet response to aspirin in patients with ischemic stroke.
    Hohlfeld T; Weber AA; Junghans U; Schumacher M; Boucher M; Schrör K; Siebler M
    Cerebrovasc Dis; 2007; 24(1):43-50. PubMed ID: 17519543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of fluid intake on stroke recurrence--a prospective study.
    Mücke S; Grotemeyer KH; Stahlhut L; Husstedt IW; Evers S
    J Neurol Sci; 2012 Apr; 315(1-2):82-5. PubMed ID: 22169398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of intravenous tirofiban and aspirin in reducing short-term and long-term neurologic deficit in patients with ischemic stroke: a double-blind randomized trial.
    Torgano G; Zecca B; Monzani V; Maestroni A; Rossi P; Cazzaniga M; Manganaro D; Boiti C; Zilioli E; Borutti G; Falaschi F; Mandelli C
    Cerebrovasc Dis; 2010 Feb; 29(3):275-81. PubMed ID: 20090319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between platelet function and recurrent ischemic vascular events after TIA and minor stroke
.
    Zhang J; Zhang J; Sun H; Ming T; Liu X; Cong Y; Li F; Li Z
    Int J Clin Pharmacol Ther; 2017 Oct; 55(10):789-797. PubMed ID: 28766499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The risk of false results in the assessment of platelet function in the absence of antiplatelet medication: comparison of the PFA-100, multiplate electrical impedance aggregometry and verify now assays.
    Can MM; Tanboğa IH; Türkyilmaz E; Karabay CY; Akgun T; Koca F; Tokgoz HC; Keles N; Ozkan A; Bezgin T; Ozveren O; Sonmez K; Sağlam M; Ozdemir N; Kaymaz C
    Thromb Res; 2010 Apr; 125(4):e132-7. PubMed ID: 19954823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized, parallel group, double-blind study of ticagrelor compared with aspirin for prevention of vascular events in patients undergoing coronary artery bypass graft operation: Rationale and design of the Ticagrelor in CABG (TiCAB) trial: An Investigator-Initiated trial.
    de Waha A; Sandner S; von Scheidt M; Boening A; Koch-Buettner K; Hammel D; Hambrecht R; Danner BC; Schöndube FA; Goerlach G; Fischlein T; Schmoeckel M; Oberhoffer M; Schulz R; Walther T; Ziegelhöffer T; Knosalla C; Schönrath F; Beyersdorf F; Siepe M; Attmann T; Misfeld M; Mohr FW; Sievers HH; Joost A; Putman LM; Laufer G; Hamm C; Zeymer U; Kastrati A; Radke PW; Lange R; Cremer J; Schunkert H
    Am Heart J; 2016 Sep; 179():69-76. PubMed ID: 27595681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bleeding evaluation during single tooth extraction in patients with coronary artery disease and acetylsalicylic acid therapy suspension: a prospective, double-blinded, and randomized study.
    Medeiros FB; de Andrade AC; Angelis GA; Conrado VC; Timerman L; Farsky P; Dib LL
    J Oral Maxillofac Surg; 2011 Dec; 69(12):2949-55. PubMed ID: 21802823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective, randomised trial of the time dependent antiplatelet effects of 500 mg and 250 mg acetylsalicylic acid i. v. and 300 mg p. o. in ACS (ACUTE).
    Zeymer U; Hohlfeld T; Vom Dahl J; Erbel R; Münzel T; Zahn R; Roitenberg A; Breitenstein S; Pap ÁF; Trenk D
    Thromb Haemost; 2017 Feb; 117(3):625-635. PubMed ID: 28102427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischaemic attack or minor stroke of presumed arterial origin.
    Algra A; de Schryver EL; van Gijn J; Kappelle LJ; Koudstaal PJ
    Cochrane Database Syst Rev; 2001; (4):CD001342. PubMed ID: 11687110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Triflusal vs aspirin for prevention of cerebral infarction: a randomized stroke study.
    Culebras A; Rotta-Escalante R; Vila J; Domínguez R; Abiusi G; Famulari A; Rey R; Bauso-Tosselli L; Gori H; Ferrari J; Reich E;
    Neurology; 2004 Apr; 62(7):1073-80. PubMed ID: 15079004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and rationale of CURRENT-OASIS 7: a randomized, 2 x 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non-ST-elevation acute coronary syndromes managed with an early invasive strategy.
    Mehta SR; Bassand JP; Chrolavicius S; Diaz R; Fox KA; Granger CB; Jolly S; Rupprecht HJ; Widimsky P; Yusuf S;
    Am Heart J; 2008 Dec; 156(6):1080-1088.e1. PubMed ID: 19033002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Secondary prevention of stroke with antiplatelet drugs].
    Diener HC
    Med Klin (Munich); 2004 Aug; 99 Suppl 1():21-5. PubMed ID: 15487854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial.
    Shinohara Y; Katayama Y; Uchiyama S; Yamaguchi T; Handa S; Matsuoka K; Ohashi Y; Tanahashi N; Yamamoto H; Genka C; Kitagawa Y; Kusuoka H; Nishimaru K; Tsushima M; Koretsune Y; Sawada T; Hamada C;
    Lancet Neurol; 2010 Oct; 9(10):959-68. PubMed ID: 20833591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent clinical trial results with antiplatelet therapy: implications in stroke prevention.
    Teal PA
    Cerebrovasc Dis; 2004; 17 Suppl 3():6-10. PubMed ID: 14730252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
    De Schryver EL; Algra A; van Gijn J
    Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Secondary prevention of ischemic stroke with low dose acetylsalicylic acid.
    Lee TK; Lien IN; Ryu SJ; Lee KY; Hu HH; Tchen PH; Chen CJ; Wu SC; Chen YC
    J Formos Med Assoc; 1990 Aug; 89(8):635-44. PubMed ID: 1981223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The value of platelet inhibitors in the secondary prophylaxis of stroke -- a review].
    Schellinger PD; Jüttler E; Meyding-Lamadé UK; Schwark C
    Fortschr Neurol Psychiatr; 2004 May; 72(5):270-81. PubMed ID: 15136948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Piracetam and platelets--a review of laboratory and clinical data.
    Evers S; Grotemeyer KH
    Pharmacopsychiatry; 1999 Mar; 32 Suppl 1():44-8. PubMed ID: 10338108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High on-treatment platelet reactivity on commonly prescribed antiplatelet agents following transient ischaemic attack or ischaemic stroke: results from the Trinity Antiplatelet Responsiveness (TRAP) study.
    Tobin WO; Kinsella JA; Coughlan T; Collins DR; O'Neill D; Murphy RP; Egan B; Tierney S; Feeley TM; McCabe DJ
    Eur J Neurol; 2013 Feb; 20(2):344-52. PubMed ID: 22994699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of low-dose ASA in prevention of secondary ischemic stroke, the ASA Study Group in Taiwan.
    Lee TK; Chan KW; Huang ZS; Ng SK; Lin RT; Po HL; Yuan RY; Lai ML; Chang TW; Yan SH; Deng JC; Liu LH; Lee KY; Lie SK; Sung SM; Hu HH
    Thromb Res; 1997 Jul; 87(2):215-24. PubMed ID: 9259112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.